# Maarten Boers

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/maarten-boers/

## Facts

| Field | Value |
| --- | --- |
| Citations | 62,055 |
| Field | Rheumatoid Arthritis Research and Therapies |
| h-index | 102 |
| i10-index | 417 |
| Last Known Institution | Amsterdam University Medical Centers |
| OpenAlex ID | https://openalex.org/A5044831604 |
| ORCID iD | https://orcid.org/0000-0002-6969-283X |
| Works | 787 |

## Researcher papers

- [EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update](https://scholariq.org/papers/eular-recommendations-for-the-management-of-rheumatoid-arthritis-with-synthetic/)
- [Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews](https://scholariq.org/papers/development-of-amstar-a-measurement-tool-to-assess-the-methodological-quality-of/)
- [American college of rheumatology preliminary definition of improvement in rheumatoid arthritis](https://scholariq.org/papers/american-college-of-rheumatology-preliminary-definition-of-improvement-in/)
- [EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update](https://scholariq.org/papers/eular-recommendations-for-the-management-of-rheumatoid-arthritis-with-synthetic-2/)
- [American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials](https://scholariq.org/papers/american-college-of-rheumatology-european-league-against-rheumatism-provisional/)
- [Core outcome measurement instruments for clinical trials in nonspecific low back pain](https://scholariq.org/papers/core-outcome-measurement-instruments-for-clinical-trials-in-nonspecific-low-back/)
- [Core outcome domains for clinical trials in non-specific low back pain](https://scholariq.org/papers/core-outcome-domains-for-clinical-trials-in-non-specific-low-back-pain/)
- [Towards global consensus on outcome measures for atopic eczema research: results of the <scp>HOME II</scp> meeting](https://scholariq.org/papers/towards-global-consensus-on-outcome-measures-for-atopic-eczema-research-results/)
- [Report from the fifth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative)](https://scholariq.org/papers/report-from-the-fifth-international-consensus-meeting-to-harmonize-core-outcome/)

## Researcher topics

- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Autoimmune and Inflammatory Disorders Research](https://scholariq.org/topics/autoimmune-and-inflammatory-disorders-research/)

## Researcher university

- [Amsterdam University Medical Centers](https://scholariq.org/institutions/amsterdam-university-medical-centers/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
